|
Name |
1-Heneicosanol
|
| Molecular Formula | C21H44O | |
| IUPAC Name* |
henicosan-1-ol
|
|
| SMILES |
CCCCCCCCCCCCCCCCCCCCCO
|
|
| InChI |
InChI=1S/C21H44O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22/h22H,2-21H2,1H3
|
|
| InChIKey |
FIPPFBHCBUDBRR-UHFFFAOYSA-N
|
|
| Synonyms |
1-Heneicosanol; Heneicosanol; 15594-90-8; henicosan-1-ol; Heneicosyl Alcohol; Henicosanol; 1-Henicosanol; Heneicosan-1-ol; 15BB7P0F03; N-HENEICOSANOL; n-henicosanol; Heneicosylalkohol; henicosyl alcohol; n-Heneikosylalkohol; EINECS 239-673-2; MFCD00062834; n-C21H43OH; SCHEMBL103723; UNII-15BB7P0F03; CHEBI:78410; DTXSID70935330; Heneicosanol, >=98.5% (GC); ZINC95731181; AKOS015839827; AS-56401; CS-0146641; FT-0607872; H0011; T71853; J-009262; Q27147812; 3DB8B333-539F-4CD9-80D1-07BEBB581BF1
|
|
| CAS | 15594-90-8 | |
| PubChem CID | 85014 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 312.6 | ALogp: | 10.0 |
| HBD: | 1 | HBA: | 1 |
| Rotatable Bonds: | 19 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 20.2 | Aromatic Rings: | 0 |
| Heavy Atoms: | 22 | QED Weighted: | 0.244 |
| Caco-2 Permeability: | -4.992 | MDCK Permeability: | 0.00000900 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.087 |
| 30% Bioavailability (F30%): | 0.998 |
| Blood-Brain-Barrier Penetration (BBB): | 0.023 | Plasma Protein Binding (PPB): | 97.63% |
| Volume Distribution (VD): | 3.517 | Fu: | 1.39% |
| CYP1A2-inhibitor: | 0.12 | CYP1A2-substrate: | 0.167 |
| CYP2C19-inhibitor: | 0.222 | CYP2C19-substrate: | 0.05 |
| CYP2C9-inhibitor: | 0.063 | CYP2C9-substrate: | 0.956 |
| CYP2D6-inhibitor: | 0.075 | CYP2D6-substrate: | 0.029 |
| CYP3A4-inhibitor: | 0.164 | CYP3A4-substrate: | 0.025 |
| Clearance (CL): | 5.177 | Half-life (T1/2): | 0.061 |
| hERG Blockers: | 0.325 | Human Hepatotoxicity (H-HT): | 0.008 |
| Drug-inuced Liver Injury (DILI): | 0.11 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.012 | Maximum Recommended Daily Dose: | 0.015 |
| Skin Sensitization: | 0.967 | Carcinogencity: | 0.029 |
| Eye Corrosion: | 0.995 | Eye Irritation: | 0.92 |
| Respiratory Toxicity: | 0.472 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000449 | ![]() |
0.955 | D00AOJ | ![]() |
0.955 | ||
| ENC000431 | ![]() |
0.953 | D07ILQ | ![]() |
0.590 | ||
| ENC000745 | ![]() |
0.906 | D00STJ | ![]() |
0.521 | ||
| ENC000359 | ![]() |
0.877 | D00FGR | ![]() |
0.495 | ||
| ENC000284 | ![]() |
0.859 | D0Z5SM | ![]() |
0.475 | ||
| ENC000432 | ![]() |
0.855 | D0O1PH | ![]() |
0.444 | ||
| ENC000282 | ![]() |
0.822 | D05ATI | ![]() |
0.405 | ||
| ENC000442 | ![]() |
0.819 | D0T9TJ | ![]() |
0.328 | ||
| ENC000750 | ![]() |
0.819 | D0P1RL | ![]() |
0.324 | ||
| ENC000486 | ![]() |
0.813 | D05ZPL | ![]() |
0.319 | ||